FDA Panel Urges Approval of Hepatitis C Drug

In an 18-0 vote, an FDA advisory panel recommended approval of the drug boceprevir to treat hepatitis C.

Click here to read the full story.

Post a Comment
 

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.